Literature DB >> 19029860

Regeneration of aged vocal fold: first human case treated with fibroblast growth factor.

Shigeru Hirano1, Yo Kishimoto, Atsushi Suehiro, Shin-ichi Kanemaru, Juichi Ito.   

Abstract

BACKGROUND/
OBJECTIVES: Aged vocal folds are characterized by atrophy of the mucosa, which causes dysphonia and is difficult to treat. We have revealed a therapeutic potential of basic fibroblast growth factor (bFGF) for tissue regeneration of the aged vocal fold. We report here the first human case that has been treated with bFGF. STUDY
DESIGN: Institutional review board approved clinical human trial.
METHODS: A 63-year-old man with atrophied vocal folds was treated by local injection of 10 muicrog of bFGF into the left vocal fold under topical anesthesia. The effects of the injection were examined after 1 to 3 months by videostroboscopy, acoustic and aerodynamic measurements.
RESULTS: The atrophy of the vocal fold was improved at 1 week after the injection and glottic gap disappeared. Aerodynamic and acoustic parameters also showed remarkable improvement. These positive effects were maintained up to 3 months.
CONCLUSION: The first case with aged vocal folds treated with bFGF administration is presented. The results are encouraging, suggesting therapeutic effects of bFGF for atrophied vocal folds in human.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029860     DOI: 10.1097/MLG.0b013e3181845720

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Local vascularized flaps for augmentation of Reinke's space.

Authors:  Seth H Dailey; McLean Gunderson; Roger Chan; Jose Torrealba; Miwako Kimura; Nathan V Welham
Journal:  Laryngoscope       Date:  2011-02       Impact factor: 3.325

2.  [Vocal fold scars: pathogenesis, diagnosis, therapy].

Authors:  G Friedrich; M Gugatschka
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

Review 3.  Vocal fold scars: current concepts and future directions. Consensus report of the Phonosurgery Committee of the European Laryngological Society.

Authors:  G Friedrich; F G Dikkers; C Arens; M Remacle; M Hess; A Giovanni; S Duflo; A Hantzakos; V Bachy; M Gugatschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-21       Impact factor: 2.503

4.  Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles.

Authors:  Richard D Andreatta; Joseph C Stemple; Tanya S Seward; Colleen A McMullen
Journal:  J Vis Exp       Date:  2017-06-13       Impact factor: 1.355

Review 5.  Characterization of vocal fold scar formation, prophylaxis, and treatment using animal models.

Authors:  Diane M Bless; Nathan V Welham
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-12       Impact factor: 2.064

6.  Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds.

Authors:  Tsunehisa Ohno; Mi Jin Yoo; Erik R Swanson; Shigeru Hirano; Robert H Ossoff; Bernard Rousseau
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-08       Impact factor: 1.547

7.  Favorable vocal fold wound healing induced by platelet-rich plasma injection.

Authors:  Seung Hoon Woo; Han-Sin Jeong; Jin Pyeong Kim; Eun-Ha Koh; Seon Uk Lee; Sung Min Jin; Dong Hoon Kim; Jin Hee Sohn; Sang Hyuk Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-02-05       Impact factor: 3.372

8.  Transient dynamic mechanical properties of resilin-based elastomeric hydrogels.

Authors:  Linqing Li; Kristi L Kiick
Journal:  Front Chem       Date:  2014-04-28       Impact factor: 5.221

9.  Enhancement of aging rat laryngeal muscles with endogenous growth factor treatment.

Authors:  Joseph C Stemple; Richard D Andreatta; Tanya S Seward; Vrushali Angadi; Maria Dietrich; Colleen A McMullen
Journal:  Physiol Rep       Date:  2016-05

10.  Fibroblast growth factors as tissue repair and regeneration therapeutics.

Authors:  Quentin M Nunes; Yong Li; Changye Sun; Tarja K Kinnunen; David G Fernig
Journal:  PeerJ       Date:  2016-01-12       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.